Ahter Dilşad Şanlioğlu

1.1k total citations
45 papers, 925 citations indexed

About

Ahter Dilşad Şanlioğlu is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Ahter Dilşad Şanlioğlu has authored 45 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 17 papers in Genetics and 12 papers in Surgery. Recurrent topics in Ahter Dilşad Şanlioğlu's work include Cell death mechanisms and regulation (19 papers), Pancreatic function and diabetes (12 papers) and Virus-based gene therapy research (8 papers). Ahter Dilşad Şanlioğlu is often cited by papers focused on Cell death mechanisms and regulation (19 papers), Pancreatic function and diabetes (12 papers) and Virus-based gene therapy research (8 papers). Ahter Dilşad Şanlioğlu collaborates with scholars based in Türkiye, United States and Poland. Ahter Dilşad Şanlioğlu's co-authors include Salih Şanlıoğlu, Thomas S. Griffith, Ercument Dirice, Mustafa Kemal Balcı, Bahri Karaçay, Çiğdem Aydın, İsmail Türker Köksal, Güven Lüleci, Nuray Erin and Sadi Köksoy and has published in prestigious journals such as The Journal of Urology, International Journal of Radiation Oncology*Biology*Physics and Cellular and Molecular Life Sciences.

In The Last Decade

Ahter Dilşad Şanlioğlu

45 papers receiving 906 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ahter Dilşad Şanlioğlu Türkiye 19 588 223 191 187 178 45 925
Maureen Spit Netherlands 11 878 1.5× 179 0.8× 177 0.9× 136 0.7× 487 2.7× 13 1.3k
Li-Jyun Syu United States 16 629 1.1× 84 0.4× 192 1.0× 167 0.9× 281 1.6× 22 1.0k
Frank Wempe Germany 17 556 0.9× 187 0.8× 86 0.5× 126 0.7× 187 1.1× 28 978
Sidhartha Tulachan United States 17 686 1.2× 277 1.2× 473 2.5× 114 0.6× 354 2.0× 27 1.2k
Konstantin V. Salojin Canada 18 571 1.0× 183 0.8× 123 0.6× 683 3.7× 225 1.3× 21 1.3k
Xiaotan T. Qiao United States 10 840 1.4× 367 1.6× 362 1.9× 198 1.1× 498 2.8× 13 1.4k
Mina Nakama Japan 11 558 0.9× 141 0.6× 103 0.5× 126 0.7× 101 0.6× 27 848
Ward Coats United States 6 540 0.9× 294 1.3× 280 1.5× 103 0.6× 145 0.8× 6 879
Wolfgang Meißner Germany 14 811 1.4× 153 0.7× 57 0.3× 228 1.2× 147 0.8× 22 1.1k
Stefan Selbert Germany 6 507 0.9× 120 0.5× 154 0.8× 140 0.7× 359 2.0× 11 824

Countries citing papers authored by Ahter Dilşad Şanlioğlu

Since Specialization
Citations

This map shows the geographic impact of Ahter Dilşad Şanlioğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahter Dilşad Şanlioğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahter Dilşad Şanlioğlu more than expected).

Fields of papers citing papers by Ahter Dilşad Şanlioğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahter Dilşad Şanlioğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahter Dilşad Şanlioğlu. The network helps show where Ahter Dilşad Şanlioğlu may publish in the future.

Co-authorship network of co-authors of Ahter Dilşad Şanlioğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Ahter Dilşad Şanlioğlu. A scholar is included among the top collaborators of Ahter Dilşad Şanlioğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahter Dilşad Şanlioğlu. Ahter Dilşad Şanlioğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Şanlioğlu, Ahter Dilşad, et al.. (2024). Gene and cell therapy of human genetic diseases: Recent advances and future directions. Journal of Cellular and Molecular Medicine. 28(17). e70056–e70056. 12 indexed citations
2.
Bişgin, Atıl, et al.. (2022). Generation of a Beta-Cell Transplant Animal Model of Diabetes Using CRISPR Technology. Advances in experimental medicine and biology. 1409. 145–159. 2 indexed citations
3.
4.
Şanlioğlu, Ahter Dilşad, et al.. (2018). High-Titer Production of HIV-Based Lentiviral Vectors in Roller Bottles for Gene and Cell Therapy. Methods in molecular biology. 1879. 323–345. 9 indexed citations
5.
Akkaya, Bahar, et al.. (2016). Analysis of TNF-related apoptosis-inducing ligand and receptors and implications in thymus biology and myasthenia gravis. Neuromuscular Disorders. 27(2). 128–135. 5 indexed citations
6.
Kahraman, Sevim, Çiğdem Aydın, Gülsüm Özlem Elpek, Ercument Dirice, & Ahter Dilşad Şanlioğlu. (2015). Diabetes-Resistant NOR Mice Are More Severely Affected by Streptozotocin Compared to the Diabetes-Prone NOD Mice: Correlations with Liver and Kidney GLUT2 Expressions. Journal of Diabetes Research. 2015. 1–8. 12 indexed citations
7.
Şanlioğlu, Ahter Dilşad, Hasan Altunbaş, Mustafa Kemal Balcı, Thomas S. Griffith, & Salih Şanlıoğlu. (2013). Clinical utility of insulin and insulin analogs. Islets. 5(2). 67–78. 45 indexed citations
8.
Şahın, Emel, Mehmet Şahin, Ahter Dilşad Şanlioğlu, & Saadet Gümüşlü. (2011). KNK437, a benzylidene lactam compound, sensitises prostate cancer cells to the apoptotic effect of hyperthermia. International Journal of Hyperthermia. 27(1). 63–73. 16 indexed citations
9.
Dirice, Ercument, Sevim Kahraman, Gülsüm Özlem Elpek, et al.. (2011). TRAIL and DcR1 Expressions Are Differentially Regulated in the Pancreatic Islets of STZ- versus CY-Applied NOD Mice. Experimental Diabetes Research. 2011. 1–11. 12 indexed citations
10.
Kahraman, Sevim, Ercument Dirice, Mustafa Gökhan Ertosun, et al.. (2011). Tracing of islet graft survival by way of in vivo fluorescence imaging. Diabetes/Metabolism Research and Reviews. 27(6). 575–583. 11 indexed citations
11.
Köksal, İsmail Türker, Ahter Dilşad Şanlioğlu, Ömer Kutlu, & Salih Şanlıoğlu. (2010). Effects of Androgen Ablation Therapy in TRAIL Death Ligand and Its Receptors Expression in Advanced Prostate Cancer. Urologia Internationalis. 84(4). 445–451. 6 indexed citations
12.
Aydın, Çiğdem, Ahter Dilşad Şanlioğlu, Atıl Bişgin, et al.. (2010). NF-κB targeting by way of IKK inhibition sensitizes lung cancer cells to adenovirus delivery of TRAIL. BMC Cancer. 10(1). 584–584. 24 indexed citations
13.
Şanlioğlu, Ahter Dilşad, Ercument Dirice, Gülsüm Özlem Elpek, et al.. (2008). High Levels of Endogenous Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Expression Correlate With Increased Cell Death in Human Pancreas. Pancreas. 36(4). 385–393. 25 indexed citations
14.
Şanlioğlu, Ahter Dilşad, Thomas S. Griffith, Abdulkadir Omer, et al.. (2008). Molecular mechanisms of death ligand‐mediated immune modulation: A gene therapy model to prolong islet survival in type 1 diabetes. Journal of Cellular Biochemistry. 104(3). 710–720. 24 indexed citations
15.
Terzıoğlu, Ender, Atıl Bişgin, Ahter Dilşad Şanlioğlu, et al.. (2007). Concurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis. Lara D. Veeken. 46(5). 783–789. 27 indexed citations
16.
Köksal, İsmail Türker, Ahter Dilşad Şanlioğlu, Bahri Karaçay, Thomas S. Griffith, & Salih Şanlıoğlu. (2007). Tumor necrosis factor-related apoptosis inducing ligand-R4 decoy receptor expression is correlated with high Gleason scores, prostate-specific antigen recurrence, and decreased survival in patients with prostate carcinoma. Urologic Oncology Seminars and Original Investigations. 26(2). 158–165. 30 indexed citations
17.
Keser, İbrahim, et al.. (2005). Identification of a Novel Frameshift Mutation [Codon 3 (+T)] in a Turkish Patient with \beta-Thalassemia Intermedia. TURKISH JOURNAL OF MEDICAL SCIENCES. 35(3). 175–177. 2 indexed citations
18.
Şanlioğlu, Ahter Dilşad, İsmail Türker Köksal, Bahri Karaçay, et al.. (2005). Adenovirus-mediated IKKβKA expression sensitizes prostate carcinoma cells to TRAIL-induced apoptosis. Cancer Gene Therapy. 13(1). 21–31. 39 indexed citations
19.
Şanlioğlu, Ahter Dilşad, Ercument Dirice, Çiğdem Aydın, et al.. (2005). Surface TRAIL decoy receptor-4 expression is correlated with TRAIL resistance in MCF7 breast cancer cells. BMC Cancer. 5(1). 54–54. 109 indexed citations
20.
Şanlioğlu, Ahter Dilşad, Bahri Karaçay, Peter K Benson, John F. Engelhardt, & Salih Şanlıoğlu. (2004). Novel approaches to augment adeno-associated virus type-2 endocytosis and transduction. Virus Research. 104(1). 51–59. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maureen Spit Breakdown of academic impact, for papers by Li-Jyun Syu Breakdown of academic impact, for papers by Frank Wempe Breakdown of academic impact, for papers by Sidhartha Tulachan Breakdown of academic impact, for papers by Konstantin V. Salojin Breakdown of academic impact, for papers by Xiaotan T. Qiao Breakdown of academic impact, for papers by Mina Nakama Breakdown of academic impact, for papers by Ward Coats Breakdown of academic impact, for papers by Wolfgang Meißner Breakdown of academic impact, for papers by Stefan Selbert
Rankless by CCL
2026